Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

DIFFORAL CAPSULES 250MG

Approval Number

SIN16932P

Drug Name

DIFFORAL CAPSULES 250MG

Product Name

DIFFORAL CAPSULES 250MG

Approval Date

January 17, 2024

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

A07AA09

ATC Item Name

vancomycin

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

Kleva Pharmaceuticals S.A.

Active Ingredients

Ingredient Name

Vancomycin Hydrochloride eqv Vancomycin

Strength

250 mg

Drug MonographVancomycin

Documents

Package Inserts

Difforal Capsule PI.pdf

Approved: January 17, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

DIFFORAL CAPSULES 250MG - HSA Approval | MedPath